Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  van Wietmarschen, Herman A ^a,b   Dai, Weidong ^c   van der Kooij, Anita J ^d   Reijmers, Theo H ^a,d   Schroën, Yan ^b,e   Wang, Mei ^b,f   Xu, Zhiliang ^g   Wang, Xinchang ^h   Kong, Hongwei ^c   Xu, Guowang ^c   Hankemeier, Thomas ^a,d   Meulman, Jacqueline J ^d   van der Greef, Jan ^a,b,f,i  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Sino Dutch Centre for Preventive and Personalized Medicine   (Netherlands)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^d LEIDEN UNIVERSITY   (Netherlands)

^e Oxrider Education and Research   (Netherlands)

^f SU BioMedicine   (Netherlands)

^g College of Life Science Company Limited ^*  (China)

^h Zhejiang Xinhua hospital Rheumatology and Immunology Department   (China)

ⁱ TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; C REACTIVE PROTEIN; PRASTERONE SULFATE; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL CHEMISTRY; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; METABOLOMICS; PATIENT CODING; PHENOTYPE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY; URINALYSIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CHEMISTRY, CLINICAL; COLD TEMPERATURE; FEMALE; HOT TEMPERATURE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDIVIDUALIZED MEDICINE; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PITUITARY-ADRENAL SYSTEM; QUESTIONNAIRES; RHEUMATOID FACTOR; RHEUMATOLOGY;

EID: 84866316346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044331     Document Type: Article

References (55)

1. Glocker MO, Guthke R, Kekow J, Thiesen H-J, (2006) Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med Res Rev 26: 63-87.
2. Isaacs JD, Ferraccioli G, (2011) The need for personalised medicine for rheumatoid arthritis. Ann Rheum Dis 70: 4-7.
3. Smolen JS, Aletaha D, (2005) Challenges of predicting treatment response in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 1: 62-63.
4. Maillefert J-F, Puéchal X, Falgarone G, Lizard G, Ornetti P, et al. (2010) Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis. Joint Bone Spine 77: 558-63.
5. van der Greef J, McBurney RN, (2005) Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nat Rev Drug Discov 4: 961-7.
6. van Baarsen LG, Wijbrandts CA, Rustenburg F, Cantaert T, van der Pouw Kraan TC, et al. (2010) Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment. Arthritis Res Ther 12(1): R11.
7. van der Pouw Kraan TCTM, Wijbrandts CA, van Baarsen LGM, Voskuyl AE, Rustenburg F, et al. (2007) Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 66: 1008-14.
8. Anderson JJ, Wells G, Verhoeven AC, Felson DT, (2000) Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 43: 22-29.
9. Wolfe F, Cathey MA, (1991) The effect of age on methotrexate efficacy and toxicity. J Rheumatol 18: 973-977.
10. Conaghan PG, (2011) Predicting outcomes in rheumatoid arthritis. Clin Rheumatol 30Suppl 1: S41-47.
11. van Wietmarschen H, Yuan K, Lu C, Gao P, Wang J, et al. (2009) Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J Clin Rheumatol 15: 330-337.
12. He Y, Lu A, Zha Y, Yan X, Song Y, et al. (2007) Correlations between symptoms as assessed in traditional chinese medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine. J Clin Rheumatol 13: 317-21.
13. Ni M (1995) The Yellow Emperor's Classic of Medicine: A New Translation of the Neijing Suwen With Commentary. Boston, MA: Shambhala.
14. Jiang WY (2005) Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends in pharmacological sciences, 26(11), 558-563.
15. Lu C, Xiao C, Chen G, Jiang M, Zha Q, et al. (2010) Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell. Rheumatology international 32(1): 61-8.
16. Jiang M, Xiao C, Chen G, Lu C, Zha Q, et al. (2011) Correlation between cold and hot pattern in traditional Chinese medicine and gene expression profiles in rheumatoid arthritis. Frontiers of medicine 5(2): 219-28.
17. Gu Y, Lu C, Zha Q, Kong H, Lu X, (2012) Plasma metabonomics study of rheumatoid arthritis and its Chinese medicine subtypes by using liquid chromatography and gas chromatography coupled with mass spectrometry. Mol BioSyst 8: 1535-1543.
18. Lu C, Zha Q, Chang A, He Y, Lu A, (2009) Pattern Differentiation in Traditional Chinese Medicine Can Help Define Specific Indications for Biomedical Therapy in the Treatment of Rheumatoid Arthritis. J Altern Complement Med 15: 1021-1025.
19. Meulman JJ, van der Kooij AJ, Heiser WJ (2004) Principal components analysis with nonlinear optimal scaling transformations for ordinal and nominal data. In: Kaplan D. The Sage handbook of quantitative methodology for the social sciences. SAGE. p. 49-70.
20. Linting M, Meulman J, Groenen P, van der Kooij A, (2007) Nonlinear principal components analysis: Introduction and application. Psychol Methods 12: 336-358.
21. Barker M, Rayens W, (2003) Partial least squares for discrimination. J Chemometr 17: 166-173.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-24.
23. van Wietmarschen HA, Reijmers TH, van der Kooij AJ, Schroën J, Wei H, et al. (2011) Sub-typing of rheumatic diseases based on a systems diagnosis questionnaire. PloS One 6: e24846.
24. Dai WD, Wei C, Kong HW, Jia ZH, Han JK, et al. (2011) Effect of the traditional Chinese medicine tongxinluo on endothelial dysfunction rats studied by using urinary metabonomics based on liquid chromatography-mass spectrometry. J Pharmaceut Biomed 56, 86-92.
25. Gika HG, Theodoridis GA, Wingate JE, Wilson DE, (2007) Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J Proteome Res 6: 3291-3303.
26. Vandeginste BGM, Massart DL, Buydens LMC, De Jong S, Lewi PJ (1998) Handbook of Chemometrics and Qualimetrics Part B. Amsterdam: Elsevier p.374.
27. Nishisato S, (1984) Forced classification: A simple application of a quantification method. Psychometrika 49: 25-36.
28. Higgins J, (2002) Nonlinear systems in medicine. The Yale journal of biology and medicine 75: 247-260.
29. Callard R, George AJ, Stark J, (1999) Cytokines, chaos, and complexity. Immunity 11(5): 507-513.
30. Linting M, van der Kooij A, (2012) Nonlinear Principal Components Analysis With CATPCA: A Tutorial. J Pers Assess 94(1): 12-25.
31. Meulman JJ, Heiser WJ (2009) SPSS Categories 17.0. Chicago, Il.: SPSS Inc.
32. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, MacDonald IA, et al. (2006) Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 78(2): 567-74.
33. Hendriks MMWB, Smit S, Akkermans WLMW, Reijmers TH, Eilers PHC, et al. (2007) How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics. Proteomics 7: 3672-3680.
34. Kind T, Fiehn O, (2010) Advances in structure elucidation of small molecules using mass spectrometry. Bioanalytical Reviews 2: 23-60.
35. Paglia G, D'Apolito O, Corso G, (2008) Precursor ion scan profiles of acylcarnitines by atmospheric pressure thermal desorption chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 22: 3809-3815.
36. McClellan JE, Quarmby ST, Yost RA, (2002) Parent and neutral loss monitoring on a quadrupole ion trap mass spectrometer: screening of acylcarnitines in complex mixtures. Anal Chem 74: 5799-5806.
37. van der Heijde DM, van 't Hof MA, van Riel PL, Theumisse LA, Lubberts EW, et al. (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49: 916-920.
38. George-Gay B, Parker K, (2003) Understanding the complete blood count with differential. J. Perianesth Nurs 18: 96-114.
39. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, et al. (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393-406.
40. Ryu H, Lee H, Kim H, Kim J, (2010) Reliability and Validity of a Cold-Heat Pattern Questionnaire for Traditional Chinese Medicine. J Altern Complem Med 16: 663-667.
41. Robinson V, Brosseau L, Casimiro L, Judd M, Shea B, et al. (2002) Thermotherapy for treating rheumatoid arthritis. Cochrane Database Syst Rev.
42. Verhagen AP, Bierma-Zeinstra SMA, Cardoso JR, de Bie RA, Boers M, et al. (2003) Balneotherapy for rheumatoid arthritis. Cochrane Database Syst Rev 4: CD000518.
43. Kang G-L, Li S, Zhang J-F, (2008) Entropy-based model for interpreting life systems in traditional chinese medicine. Evid-Based Compl Alt 5: 273-279.
44. van der Helm-van Mil AHM, Verpoort KN, Breedveld FC, Toes REM, Huizinga TWJ, (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7: R949-58.
45. Kazory A, (2010) Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 106: 694-700.
46. Dessein PH, Woodiwiss AJ, Joffe BI, Norton GR, (2007) Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis. BMC Cardiov Dis 7: 31.
47. Sewell AC, Böhles HJ, (1995) Acylcarnitines in intermediary metabolism. Eur J Pediatr 154: 871-877.
48. Jones MG, Goodwin CS, Amjad S, Chalmers RA, (2005) Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndrome. Clin Chim Acta 360: 173-177.
49. Krähenbühl S, Willer B, Brühlmann P, Hoppeler H, Stucki G, (1999) Carnitine homeostasis in patients with rheumatoid arthritis. Clin Chim Acta 279: 35-45.
50. Patterson AD, Krausz KW, Li F, Ho CC, Gonzalez FJ, et al. (2009) Human Urinary Metabolomic Profile of PPARr Induced Fatty Acid-Oxidation research articles. J Proteome Res 4293-4300.
51. Guebre-Egziabher F, Rabasa-Lhoret R, Bonnet F, Bastard J-P, Desage M, et al. (2008) Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur J Clin Nutr 62: 1287-1293.
52. Reuter SE, Evans AM, (2011) Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. J Intern Med 270: 76-84.
53. Khan NA, Spencer HJ, Abda E, Aggarwal A, Alten R, et al. (2012) Determinants of discordance in patient's and physician's rating of rheumatoid arthritis disease activity. Arthrit Care Res 64: 206-214.
54. Cutolo M, Villaggio B, Foppiani L, Briata M, Sulli A, et al. (2000) The hypothalamic-pituitary-adrenal and gonadal axes in rheumatoid arthritis. Ann Ny Acad Sci 917: 835-43.
55. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, et al. (2007) Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol 1: 51-60.